Rybelsus (semaglutide) is an FDA-approved oral medication classified as a glucagon-like peptide 1 (GLP-1). It is taken daily to manage blood sugar levels in patients with type 2 diabetes. Rybelsus 14mg is an oral medication specifically designed for managing type 2 diabetes by lowering blood sugar levels. Patients prescribed Rybelsus must follow a strict dietary […]